June 25, 2026 Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development
June 25, 2026 Tonkatsu Becomes a Must-Try for Japan Visitors: Which Chains Do Japanese Consumers Prefer?
